- Company to host conference call and live webcast on
Thursday, June 29, at 8:30 am ET
PALO
ALTO, Calif., June 28,
2023 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc.
(Nasdaq: EIGR), a commercial-stage biopharmaceutical company
focused on the development of innovative therapies for rare
diseases, today announced that following an extensive portfolio
prioritization exercise, the company will host a conference call
and live webcast on Thursday, June
29, at 8:30 am ET.
Conference Call Details
The live and replayed
webcast of the call will be available through the company's website
at www.eigerbio.com. To participate in the live call by phone, dial
(866) 524-3160 (U.S.) or (412) 317-6760 (International).
The webcast will be archived and available for replay for at least
90 days after the event.
For additional information about Eiger and its clinical
programs, please visit www.eigerbio.com.
Investors:
Sylvia Wheeler
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com
Media:
Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-host-business-update-call-tomorrow-301866246.html
SOURCE Eiger BioPharmaceuticals, Inc.
